Drakenterprises
CardiologyDiabetesFamily MedicineEmergencyOrthopaedicsOtolaryngologyOncologyCross-cutting

Not clinical advice. Clinical Evidence is a current-awareness feed. It is not a clinical decision-support system, not medical advice, and not a substitute for clinical judgment, institutional protocols, or the original sources. Full text, NCCN recommendations, and Cochrane review bodies are not reproduced here.

Home · cross-cutting

CochraneSystematic review

Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.

The Cochrane database of systematic reviews · Cochrane · 08/17/2026

Authors: Awedew, Atalel F; Fentahun Emrie, Assefa; Jegnie, Mihretu; Morales, Luis; supported by the Cochrane Hepato-Biliary Group

Publication types: Journal Article

PubMed abstract / permitted excerpt

This is a protocol for a Cochrane review (intervention). The objectives are as follows: To assess the benefits and harms of intravenous administration of gemcitabine monotherapy or gemcitabine-based combination chemotherapy versus placebo or non-gemcitabine-based chemotherapy in people with advanced biliary tract carcinomas.

Full-text bodies are not stored. Link to the Cochrane Library. Do not republish review bodies.

Clinical Evidence